+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anthera Pharmaceuticals Inc  - logo

Anthera Pharmaceuticals is a biopharmaceutical company that specializes in products to treat serious diseases associated with inflammation and autoimmune diseases. The company has two product candidates in development. Sollpura is a biotechnology-derived pancreatic enzyme replacement therapy for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. Blisibimod is a BAFF inhibitor for the potential treatment of IgA nephropathy. The company was founded in 2004 and is headquartered in Hayward, California.

From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • December 2023
  • 182 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • December 2023
  • 192 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 450 Pages +
  • Global
From
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2023 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2023

  • Report
  • September 2023
  • 300 Pages
  • Global
From
Ascites Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Ascites Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 137 Pages
  • Global
From
From
From
Gaucher Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report

  • Report
  • December 2023
  • 194 Pages
  • Global
From
From
From
Loading Indicator